From: Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting
Type of PACD
Number of patients
Number of medications
Acute primary angle closure (n = 8)
2/8 (25.0%)
6
Chronic primary angle closure
PACS (n = 19)
3/19 (15.8%)
3
PAC (n = 13)
1/13 (7.7%)
PACG (n = 3)
2/3 (66.7%)
TOTAL
8/43 (18.6%)
15